RxSight (NASDAQ:RXST – Get Free Report) had its target price raised by Oppenheimer from $54.00 to $61.00 in a research report issued on Thursday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s price objective points to a potential upside of 8.73% from the company’s previous close. Several other equities analysts […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report) was the target of a large decrease in short interest in December. As of December 15th, there was short interest totalling 1,100,000 shares, a decrease of 16.7% from the November 30th total of 1,320,000 shares. Based on an average trading volume of 534,300 shares, the days-to-cover ratio is […]
RxSight (NASDAQ:RXST) Lifted to Overweight at Wells Fargo & Company theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
RxSight, Inc. (NASDAQ:RXST – Get Free Report) Director Robert Keith Warner sold 14,502 shares of RxSight stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $35.01, for a total transaction of $507,715.02. Following the sale, the director now owns 29,248 shares of the company’s stock, valued at […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report) Director Robert Keith Warner sold 14,502 shares of the company’s stock in a transaction that occurred on Friday, December 8th. The shares were sold at an average price of $35.01, for a total value of $507,715.02. Following the completion of the sale, the director now owns 29,248 shares […]